Company Info
Phone(646) 690-7620
Year Established
2005
Ticker
SNDX
Exchange
NASDAQ
Contacts
Michael A. MetzgerCEO
Anjali Ganguli, Ph.D.
CBO
Steven Closter
CCO
Keith A. Goldan
CFO
Kate Madigan, M.D.
CMO
Peter Ordentlich, Ph.D.
Founder & CSO
Luke J. Albrecht
General Counsel
Neil Gallagher, M.D., Ph.D.
President & Head of R&D
Company Description
Syndaxis is a late-stage biopharmaceutical company focused on developing a pipeline of combination therapies in multiple cancer indications.
